Subject One: Scan 1

(4/3/02 – 4/22/03)

Fig. 1. Improvement in bone density a subject (female, age 59 years) taking a new calcium balancing formula. Subject volunteered for a 4 month safety evaluation period after a preliminary scan (DEXA) revealed the presence of mild osteopenia. Subject completed the safety evaluation period with no side effects or problems with formula. Subject returned to be retested 8 months after the end of the evaluation period (12 months after first scan). The second scan revealed that BMD (g/cm2) had increased from an initial score of .671 to .712 (yellow highlighted area), indicating a 6.1% increase in bone density.